For the eighth time, Sullivan & Cromwell has been recognized by Law360 as an M&A “Practice Group of the Year”. In 2022, S&C led all law firm advisers in announced M&A deals—working on announced deals totaling $516.6 billion worldwide, representing a 14 percent market share.
Our recent achievements in M&A include:
- Preserving the value of Biohaven’s pipeline assets in its $11.6 billion merger with Pfizer
- Overcoming challenges to complete UnitedHealthGroup’s $13.8 billion acquisition of Change Healthcare
- Executing a demerger to complete Haleon’s $36 billion spin-off from GSK
- Representing First Horizon in its pending $13.4 billion sale to Toronto Dominion
- Advising Porsche SE in its €10.1 billion investment in Porsche AG
S&C’s Mergers & Acquisitions Group brings a rare combination of creativity and commercial sensitivity to every representation. The world’s most influential companies repeatedly turn to us for their most significant matters, drawn to our dedication to client service, attention to detail and commercial pragmatism.
Recent Thought Leadership